AAAAAA

   
Results: 1-15 |
Results: 15
Association of a POEMS syndrome and light chain deposit disease: first case report
Authors: Lambotte, O Durrbach, A Ammor, M Paradis, V Djeffal, R Machover, D Charpentier, B
Citation: O. Lambotte et al., Association of a POEMS syndrome and light chain deposit disease: first case report, CLIN NEPHR, 55(6), 2001, pp. 482-486
Overview of clinical trials with new agents
Authors: Charpentier, B Hiesse, C Durrbach, A Ammor, M Von Ey, F Kechrid, C Kriaa, F
Citation: B. Charpentier et al., Overview of clinical trials with new agents, TRANSPLAN P, 33(3), 2001, pp. 2201-2203
Targeting additional costimulatory pathways: A subtle role for CD2
Authors: Dumont, C Deas, O Hebib, C Durrbach, A Hirsch, F Charpentier, B Senik, A
Citation: C. Dumont et al., Targeting additional costimulatory pathways: A subtle role for CD2, TRANSPLAN P, 33(1-2), 2001, pp. 199-200
Mortality and long term outcome of combined liver and kidney transplantations
Authors: Ammor, M Creput, C Durrbach, A Samuel, D Von Ey, F Hiesse, C Droupy, S Kriaa, F Kreis, H Benoit, G Blanchet, P Bismuth, H Charpentier, B
Citation: M. Ammor et al., Mortality and long term outcome of combined liver and kidney transplantations, TRANSPLAN P, 33(1-2), 2001, pp. 1179-1180
Truncated brush border myosin I affects membrane traffic in polarized epithelial cells
Authors: Durrbach, A Raposo, G Tenza, D Louvard, D Coudrier, E
Citation: A. Durrbach et al., Truncated brush border myosin I affects membrane traffic in polarized epithelial cells, TRAFFIC, 1(5), 2000, pp. 411-424
Diffuse colitis during mycophenolate mofetil treatment: a case report.
Authors: Khoury, N Ammor, M Durrbach, A Kriaa, F Charpentier, B
Citation: N. Khoury et al., Diffuse colitis during mycophenolate mofetil treatment: a case report., NEPHROLOGIE, 21(8), 2000, pp. 437-439
Treatment with mycophenolate mofetil in long-term renal transplant recipients: Single-center experience in 28 patients
Authors: Djeffal, R Hiesse, C Kriaa, F Hafi, A Boubenider, S Ammor, M Durrbach, A Von Ey, F Droupy, S Hammoudi, Y Eschwege, P Benoit, G Charpentier, B
Citation: R. Djeffal et al., Treatment with mycophenolate mofetil in long-term renal transplant recipients: Single-center experience in 28 patients, TRANSPLAN P, 32(8), 2000, pp. 2765-2766
Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies
Authors: Charpentier, B Hiesse, C Marchand, S Boubenider, S Ammor, M Kechrid, C Benoit, G Durrbach, A
Citation: B. Charpentier et al., Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies, TRANSPLAN P, 32(2), 2000, pp. 367-367
Cytokine expression in peripheral CD57(+) T cells from tolerant renal allograft recipients
Authors: Hebib, C Rouleau, M Hirsch, F Durrbach, A Legendre, C Senik, A Charpentier, B
Citation: C. Hebib et al., Cytokine expression in peripheral CD57(+) T cells from tolerant renal allograft recipients, TRANSPLAN P, 32(2), 2000, pp. 386-387
Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult
Authors: Dumont, C Durrbach, A Bidere, N Rouleau, M Kroemer, G Bernard, G Hirsch, F Charpentier, B Susin, SA Senik, A
Citation: C. Dumont et al., Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult, BLOOD, 96(3), 2000, pp. 1030-1038
Association of myosin I alpha with endosomes and lysosomes in mammalian cells
Authors: Raposo, G Cordonnier, MN Tenza, D Menichi, B Durrbach, A Louvard, D Coudrier, E
Citation: G. Raposo et al., Association of myosin I alpha with endosomes and lysosomes in mammalian cells, MOL BIOL CE, 10(5), 1999, pp. 1477-1494
Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 andPOMp100 DNA homologous pairing activities are associated to cell proliferation
Authors: Bertrand, P Akhmedov, AT Delacote, F Durrbach, A Lopez, BS
Citation: P. Bertrand et al., Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 andPOMp100 DNA homologous pairing activities are associated to cell proliferation, ONCOGENE, 18(31), 1999, pp. 4515-4521
Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro
Authors: Durrbach, A Angevin, E Poncet, P Rouleau, M Chavanel, G Chapel, A Thierry, D Gorter, A Hirsch, R Charpentier, B Senik, A Hirsch, F
Citation: A. Durrbach et al., Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro, CANC GENE T, 6(6), 1999, pp. 564-571
De novo and recurrent diseases: Recurrent glomerulopathies
Authors: Charpentier, B Hiesse, C Marchand, S Boubenider, S Durrbach, A Kriaa, F
Citation: B. Charpentier et al., De novo and recurrent diseases: Recurrent glomerulopathies, TRANSPLAN P, 31(1-2), 1999, pp. 264-266
Peripheral blood T cells generated after allogeneic bone marrow transplantation: Lower levels of Bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles
Authors: Hebib, NC Deas, O Rouleau, M Durrbach, A Charpentier, B Beaujean, F Vernant, JP Senik, A
Citation: Nc. Hebib et al., Peripheral blood T cells generated after allogeneic bone marrow transplantation: Lower levels of Bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles, BLOOD, 94(5), 1999, pp. 1803-1813
Risultati: 1-15 |